Bilcare Pharma Solutions Limited
About Bilcare Pharma Solutions Limited
Data last updated:
Bilcare Pharma Solutions Limited is a public limited company based in Khed, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 December 2023.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U32509PN2023PLC226463.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepa Mathur (Non- Individual Subscriber) and Kavita Sumit Bhansali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1028 Shiroli Rajgurunagar Taluka Khed, Maharashtra, India – 410505.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.15 Lakh. For the same year it recorded a net profit of ₹3.79 Lakh (net margin 7%) and EBITDA of ₹34.71 Lakh (EBITDA margin 64.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1028 Shiroli Rajgurunagar Taluka Khed, Maharashtra, India – 410505
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bilcare Pharma Solutions Limited
The main business activity of Bilcare Pharma Solutions is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bilcare Pharma Solutions Limited FY 2025 filings available
Bilcare Pharma Solutions Limited reported revenue of ₹54.15 Lakh for FY 2025.
Financial Statement Summary of Bilcare Pharma Solutions Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹34.71 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹3.79 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Bilcare Pharma Solutions Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 64.1% | •••• |
| Net Profit Margin | 7% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bilcare Pharma Solutions are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bilcare Pharma Solutions Limited
Bilcare Pharma Solutions Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aver Pharmaceuticals Private Limited | ₹54.58 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Delhi, India |
| Gitvin Remedies (GR) Private Limited | ₹54.53 Lakh (FY 2025) | •••• | •••• | -36.0% | •••• | Ahmedabad, Gujarat, India |
| Lamium Pharmaceuticals Private Limited | ₹54.41 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Pune, Maharashtra, India |
| SLB Healthcare Private Limited | ₹54.38 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Panchkula, Haryana, India |
| Qualis Health Care Formulations Private Limited | ₹54.28 Lakh (FY 2017) | •••• | •••• | -25.0% | •••• | Kozhikode, Kerala, India |
| Bilcare Pharma Solutions Limited this company | ₹54.15 Lakh (FY 2025) | •••• | •••• | •••• | Khed, Maharashtra, India | |
| Riobliss Life Sciences Private Limited | ₹54.04 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Licot Formulations Private Limited | ₹53.94 Lakh (FY 2024) | •••• | •••• | -41.0% | •••• | Srinagar, Jammu and Kashmir, India |
| Kiara Pharmaceuticals Private Limited | ₹53.87 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Catch Formulations Private Limited | ₹53.86 Lakh (FY 2018) | •••• | •••• | 165.0% | •••• | Patna, Bihar, India |
| North Bengal Trading Agencies Private Limited | ₹53.78 Lakh (FY 2025) | •••• | •••• | 55.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Bilcare Pharma Solutions by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bilcare Pharma Solutions Limited
Bilcare Pharma Solutions has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suyog Mangesh Bagul Also directs: Pune E - Stock Broking Limited | Additional Director | 09 Jan 2025 | 1 Years 8 Months | Current |
| Deepa Mathur | Non- Individual Subscriber | 18 Dec 2023 | 2 Years 9 Months | Current |
| Kavita Sumit Bhansali Also directs: Bilcare Limited | Director | 18 Dec 2023 | 2 Years 9 Months | Current |
Charges & Borrowings of Bilcare Pharma Solutions Limited
Bilcare Pharma Solutions Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bilcare Pharma Solutions Limited
Employment history and EPFO contributions of people linked to Bilcare Pharma Solutions.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Bilcare Pharma Solutions Limited
Recent Activity on Bilcare Pharma Solutions Limited
Bilcare Pharma Solutions Limited has 8 board changes on record since 2023: 7 appointments and 1 cessation. The latest: Abhigyan Upadhyay ceased to be Director on 09 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Bilcare Pharma Solutions Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bilcare Pharma Solutions Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bilcare Pharma Solutions Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bilcare Pharma Solutions Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bilcare Pharma Solutions Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bilcare Pharma Solutions Limited
Bilcare Pharma Solutions is an active public limited company based in Khed, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 December 2023 (3+ years old) and is registered under CIN U32509PN2023PLC226463.
Bilcare Pharma Solutions reported revenue of ₹54.15 Lakh for FY 2025.
Bilcare Pharma Solutions has 3 current directors:
- Suyog Mangesh Bagul - Additional Director
- Kavita Sumit Bhansali - Director
- Deepa Mathur - Non- Individual Subscriber
Bilcare Pharma Solutions reported a net profit of ₹3.79 Lakh (net margin 7%) and EBITDA of ₹34.71 Lakh (EBITDA margin 64.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Bilcare Pharma Solutions is U32509PN2023PLC226463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bilcare Pharma Solutions was incorporated on 18 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Bilcare Pharma Solutions by revenue are Aver Pharmaceuticals Private Limited, Gitvin Remedies (GR) Private Limited, Lamium Pharmaceuticals Private Limited, SLB Healthcare Private Limited, Qualis Health Care Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Abhigyan Upadhyay ceased to be Director on 09 Jan 2025. Suyog Mangesh Bagul was appointed as Additional Director on 09 Jan 2025. Ankita Jayesh Kariya was appointed as Individual Subscriber on 18 Dec 2023. Bilcare Pharma Solutions has 8 board changes on record in total.
The registered office of Bilcare Pharma Solutions is at 1028 Shiroli Rajgurunagar Taluka Khed, Maharashtra, India – 410505.
Bilcare Pharma Solutions has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Bilcare Pharma Solutions operates in the pharma industry, in the drug formulation and development segment.